GlassScriptPhysician profile
Angela White
NPI 1659829240
$3,266.39
in general payments reported to CMS, 2019-2025
33 companies · $938 in 2025
The $938 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $196 · 2022: $482 · 2023: $752 · 2024: $899 · 2025: $938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,504 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,503.98 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $760.92 | 2021-2025 | |
| Novo Nordisk INC | $357.69 | 2021-2025 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $259.16 | 2022-2025 | Veozah |
| Pfizer INC. | $189.55 | 2022-2025 | |
| Amgen INC. | $147.75 | 2022-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $143.91 | 2021-2025 | Bevespi Aerosphere, Breztri, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $138.73 | 2022-2025 | |
| Lilly USA, LLC | $129.74 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $107.01 | 2023-2025 | Cologuard Collection Kit |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $106.29 | 2023-2025 | Caplyta |
| Merck Sharp & Dohme LLC | $105.43 | 2022-2025 | Verquvo, Gardasil 9, Capvaxive |
| Glaxosmithkline, LLC. | $82.85 | 2021-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Axsome Therapeutics, INC. | $78.71 | 2022-2025 | Auvelity |
| Esperion Therapeutics, INC. | $71.82 | 2021-2025 | Nexletol |
| Phathom Pharmaceuticals, INC. | $66.40 | 2024 | Voquezna |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $61.70 | 2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $57.57 | 2025 | Jornay Pm |
| Xeris Pharmaceuticals, INC. | $57.17 | 2023-2024 | Gvoke Hypopen |
| Novartis Pharmaceuticals Corporation | $43.04 | 2022-2023 | |
| Otsuka America Pharmaceutical, INC. | $39.03 | 2023 | Rexulti |
| Philips North America LLC | $36.02 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.01 | 2025 | Jardiance |
| Mylan Specialty L.P. | $29.09 | 2022 | |
| Ironshore Pharmaceuticals INC. | $22.86 | 2024 | |
| Abbott Laboratories | $18.84 | 2025 | Freestyle Libre 3 |
| Daiichi Sankyo INC. | $17.96 | 2025 | Injectafer |
| Eisai INC. | $17.45 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.33 | 2025 | Xifaxan |
| Abiomed | $16.08 | 2024 | Impella |
| Halozyme INC | $15.77 | 2023 | |
| Sanofi Pasteur INC. | $15.08 | 2023 | |
| Supernus Pharmaceuticals, INC. | $13.67 | 2025 | Tlando, Xyosted, Qelbree |
| Biohaven Pharmaceutical Holding Company LTD. | $11.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.